Annual Current Liabilities
$142.23 M
+$63.31 M+80.22%
December 31, 2023
Summary
- As of February 7, 2025, ATRA annual total current liabilities is $142.23 million, with the most recent change of +$63.31 million (+80.22%) on December 31, 2023.
- During the last 3 years, ATRA annual current liabilities has risen by +$59.33 million (+71.56%).
- ATRA annual current liabilities is now at all-time high.
Performance
ATRA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$155.98 M
+$7.71 M+5.20%
September 30, 2024
Summary
- As of February 7, 2025, ATRA quarterly total current liabilities is $155.98 million, with the most recent change of +$7.71 million (+5.20%) on September 30, 2024.
- Over the past year, ATRA quarterly current liabilities has increased by +$13.75 million (+9.67%).
- ATRA quarterly current liabilities is now -13.68% below its all-time high of $180.69 million, reached on March 31, 2024.
Performance
ATRA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ATRA Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +80.2% | +9.7% |
3 y3 years | +71.6% | +109.2% |
5 y5 years | +255.8% | +109.2% |
ATRA Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +80.2% | -13.7% | +137.4% |
5 y | 5-year | at high | +287.1% | -13.7% | +394.9% |
alltime | all time | at high | >+9999.0% | -13.7% | >+9999.0% |
Atara Biotherapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $155.98 M(+5.2%) |
Jun 2024 | - | $148.27 M(-17.9%) |
Mar 2024 | - | $180.69 M(+27.0%) |
Dec 2023 | $142.23 M(+80.2%) | $142.23 M(+79.8%) |
Sep 2023 | - | $79.09 M(+6.1%) |
Jun 2023 | - | $74.55 M(+9.8%) |
Mar 2023 | - | $67.88 M(-14.0%) |
Dec 2022 | $78.92 M(-25.4%) | $78.92 M(+9.2%) |
Sep 2022 | - | $72.24 M(+10.0%) |
Jun 2022 | - | $65.69 M(-35.3%) |
Mar 2022 | - | $101.56 M(-4.0%) |
Dec 2021 | $105.79 M(+27.6%) | $105.79 M(+22.8%) |
Sep 2021 | - | $86.15 M(-3.0%) |
Jun 2021 | - | $88.83 M(+5.5%) |
Mar 2021 | - | $84.19 M(+1.6%) |
Dec 2020 | $82.90 M(+125.6%) | $82.90 M(+129.9%) |
Sep 2020 | - | $36.05 M(+13.8%) |
Jun 2020 | - | $31.68 M(+0.5%) |
Mar 2020 | - | $31.52 M(-14.2%) |
Dec 2019 | $36.74 M | $36.74 M(+19.7%) |
Sep 2019 | - | $30.71 M(+19.0%) |
Jun 2019 | - | $25.80 M(+2.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $25.18 M(-37.0%) |
Dec 2018 | $39.98 M(+44.6%) | $39.98 M(+48.1%) |
Sep 2018 | - | $27.00 M(-0.9%) |
Jun 2018 | - | $27.23 M(+29.4%) |
Mar 2018 | - | $21.05 M(-23.9%) |
Dec 2017 | $27.65 M(+185.7%) | $27.65 M(+67.4%) |
Sep 2017 | - | $16.52 M(+43.9%) |
Jun 2017 | - | $11.48 M(+47.1%) |
Mar 2017 | - | $7.80 M(-19.3%) |
Dec 2016 | $9.68 M(-0.4%) | $9.68 M(-29.3%) |
Sep 2016 | - | $13.69 M(+36.8%) |
Jun 2016 | - | $10.01 M(+12.9%) |
Mar 2016 | - | $8.86 M(-8.7%) |
Dec 2015 | $9.71 M(+256.4%) | $9.71 M(+50.5%) |
Sep 2015 | - | $6.45 M(-44.6%) |
Jun 2015 | - | $11.64 M(+231.4%) |
Mar 2015 | - | $3.51 M(+29.0%) |
Dec 2014 | $2.72 M(+78.7%) | $2.72 M(+12.9%) |
Sep 2014 | - | $2.41 M(+14.8%) |
Jun 2014 | - | $2.10 M(-24.6%) |
Mar 2014 | - | $2.79 M(+82.9%) |
Dec 2013 | $1.52 M(+17.1%) | $1.52 M |
Dec 2012 | $1.30 M | - |
FAQ
- What is Atara Biotherapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual current liabilities year-on-year change?
- What is Atara Biotherapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly current liabilities year-on-year change?
What is Atara Biotherapeutics annual total current liabilities?
The current annual current liabilities of ATRA is $142.23 M
What is the all time high annual current liabilities for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual total current liabilities is $142.23 M
What is Atara Biotherapeutics annual current liabilities year-on-year change?
Over the past year, ATRA annual total current liabilities has changed by +$63.31 M (+80.22%)
What is Atara Biotherapeutics quarterly total current liabilities?
The current quarterly current liabilities of ATRA is $155.98 M
What is the all time high quarterly current liabilities for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly total current liabilities is $180.69 M
What is Atara Biotherapeutics quarterly current liabilities year-on-year change?
Over the past year, ATRA quarterly total current liabilities has changed by +$13.75 M (+9.67%)